-
Current Recommendation: Celldex Therapeutics (Nasdaq: CLDX) December 28, 2009
Posted in First Access.
No comments -
Current Recommendation: Delcath Systems Inc. (Nasdaq: DCTH) December 28, 2009
Posted in First Access.
No comments
Posted in First Access.
No commentsPosted in First Access.
No comments